Access to innovation
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard...
Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally...
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard...
We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for...
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di...
Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating...
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di...
Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000...
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by N...
In combination with either atezolizumab or durvalumab.
#AseBioID24 | "AseBio Investor Day is a unique meeting point for companies and investors s...
With the aim of analyzing the Spanish biotechnological ecosystem and delving into the challenges and opportunities it...
Revolution in Pain Management straight from Spain: Introducing the Spinally Medical
Spinally Medical introduces FuturaLead™, a subarachnoid device for spinal cord stimulation aimed at patients suffering...
The Spanish AI Healthcare Landscape
While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare...